Patents by Inventor Clare Louise Doris

Clare Louise Doris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cancer by stimulation of IL-12 production
    Patent number: 11382902
    Abstract: The present invention relates to a compound and composition for use in the stimulation of IL-12 production and IFN-? production, which compound is selected from: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alaninate, or a pharmaceutically acceptable salt, hydrate or solvate thereof; and N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alanine.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: July 12, 2022
    Inventors: David Festus Charles Moffat, Martin John Perry, Stephen Mark Anderton, Clare Louise Doris
  • TREATMENT OF CANCER BY STIMULATION OF IL-12 PRODUCTION
    Publication number: 20200360359
    Abstract: The present invention relates to a compound and composition for use in the stimulation of IL-12 production and IFN-? production, which compound is selected from: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alaninate, or a pharmaceutically acceptable salt, hydrate or solvate thereof; and N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alanine.
    Type: Application
    Filed: August 30, 2018
    Publication date: November 19, 2020
    Applicant: Macrophage Pharma Limited
    Inventors: David Festus Charles Moffat, Martin John Perry, Stephen Mark Anderton, Clare Louise Doris